FDA Enforcement Weekly: Supplements, Cosmetics & Food The FDA actions that actually touch your world, in plain English. For QA & regulatory teams.

This week: moringa recall #8 (Foods Alive) · 3 supplements recalled for hidden drugs · one jalapeño importer, five Class I recalls downstream · 5 warning letters to peptide sellers in one day · a Long Island deli maker's second Listeria recall of the year · the Chilean blueberry E. coli outbreak reaches Walmart's house brand.

⭐ Item of the week: moringa recall number eight, caught by someone else's test

Last week this digest counted seven Salmonella recalls of moringa and greens powders since May. On September 4 it became eight: Foods Alive Inc. (Angola, IN) recalled 8 oz pouches of organic moringa leaf powder, lot 02726, shipped January 27 through August 7, sold nationwide and on foodsalive.com (FDA announcement; enforcement class and number pending in openFDA).

The sentence to read twice is how they found out. In Foods Alive's own words: "our supplier notified us that a sample of their super green powder mix, collected at retail, tested positive." Not their product. Not their test. A supplier's blend, pulled off a shelf somewhere by FDA, and the supplier did the right thing and phoned its customers.

The supplier is not named. For what it is worth, exactly one public event this summer matches that description: the August 7 Food To Live recall, triggered by an FDA retail sample of its Organic Supergreens Mix. That is our inference, not a confirmed link, and Foods Alive has not said. (Background: FDA's January 2026 outbreak investigation into moringa leaf powder is the reason the agency has been sampling this category all year.)

Why it happened (plain English): the powder sat on shelves for seven months. Nothing in Foods Alive's own process caught it, because nothing in the process was looking: incoming botanical powder was accepted on the supplier's paperwork, the same failure as the previous seven. The only reason it surfaced at all is that a regulator sampled a different product from the same source.

Who else should care: anyone who buys botanical powders from a shared bulk supplier. If your supplier sells the same lot to ten brands, one FDA retail sample of any of those ten brands is your recall. You will find out the way Foods Alive did, by phone, months later, if the supplier is honest. The question from last week stands: how would you find out if they were not?

Verify: FDA recall announcements; enforcement record pending.

Get this every week, free. One email each Wednesday, the FDA actions that touch supplements, cosmetics and food, in plain English.

Also this week

• 🔴 Two supplements recalled for hidden prescription drugs, both flagged by FDA in June. Ana Salazar Modela Tu Cuerpo Inc. recalled Lipofit Extreme Fat Burner 2.0 (lot 25M12F) on August 27: FDA lab analysis found undeclared fluoxetine in the AM tablets and 2,4-dinitrophenol (DNP) in the PM tablets. DNP is an industrial chemical that has killed people at supplement doses (FDA announcement). SUPPLX.com recalled Business Pill and Branch Manager for Men on September 3 for undeclared yohimbine, covering every lot sold from September 2023 to June 2026, almost three years of product (FDA announcement). And now in openFDA: ZMB Enterprises' Addall XR Shot, a liquid "focus" supplement sold on addallxr.com, Class I for containing 1,4-DMAA, phenylethylamine and phenibut (H-1263-2026), initiated April 3 and only published September 2. Why it matters: FDA published "hidden ingredient" consumer advisories for the first two products in June; the recalls came ten to twelve weeks later, and the third took five months to reach the public record. If you sell in the weight-loss or sexual-enhancement categories, FDA is buying and lab-testing your shelf, and the advisory page is public months before the recall.

• 🔴 Five warning letters to peptide sellers in one day. On September 1 FDA posted letters, all dated August 24, to Peptide Partners, NuScience Peptides, Tex Peptides (TXP Innovations), Royal Peptides and Peak Performance Peptides, all "Unapproved New Drugs / Misbranded," for selling injectable semaglutide, tirzepatide, retatrutide, PT-141 and similar as "research" products (FDA warning letters). Why it matters: the "for research use only" label stopped working. If a supplement or wellness brand has a peptide line, this is the sweep that says the category is now on the list.

• 🔴 One jalapeño importer, five Class I recalls, all now in openFDA. Coast Citrus Distributors (San Diego, CA, trading as Coast Tropical) recalled bulk Mexican jalapeños for Salmonella Javiana, sold to wholesalers and "further distributed nationwide" (H-1242-2026, initiated July 22). Then the downstream: repackers Sirna & Sons Produce (H-1262-2026), Dairyland Produce (H-1256-2026) and Get Fresh Produce (H-1257-2026), and Whole Foods' own pico de gallo and guacamole, "made with jalapenos that may be contaminated" (WFM Purchasing, H-1249-2026). Every one Class I, every one initiated in the first week of August. Why it matters: the brand on the guacamole tub never bought from the importer. Three companies sat between them. Same shape as the milk-powder cascade in May and the moringa story above, now with recall numbers you can look up.

• ⚪ Byron White Formulas (Santa Rosa, CA), three herbal supplement tinctures, Class II, because the label "does not declare walnuts in English" (H-1276 to H-1278-2026; the black-walnut-hull ingredient was listed only by its Latin name, Juglans nigra). Why it matters: a botanical name is not an allergen declaration. If your label lists an ingredient by Latin binomial only, FDA reads that as undeclared.

• 🟡 Made Fresh Salads (Bay Shore, NY), all ready-to-eat deli salads and cream cheese, Listeria, September 6. Distributed to stores in Brooklyn, Queens, the Bronx and Manhattan (FDA announcement). Why it matters: this is the same firm's second Listeria recall this year. In February it recalled thirteen cream cheese SKUs, all Class I (H-0555 to H-0567-2026, now Terminated). A "Terminated" status means FDA accepted the corrective action. Seven months later the same organism is back across the whole product line, which is the pattern that turns a recall into an inspection.

• 🟡 The Chilean blueberry outbreak reached Walmart's house brand. Frutas y Hortalizas del Sur (San Carlos, Chile) expanded its July E. coli O145 recall of frozen organic blueberries to one lot of Great Value Organic Triple Berry Blend sold in 16 states; 17 illnesses are tied to the wider outbreak (FDA announcement). Why it matters: same mechanism as the milk-powder cascade in May and the moringa story above. One imported ingredient, one lot, and two months later a private label the importer never sold to directly is on the recall list.

• ⚪ LMSI LLC / Kofinas Olive Oil (Cincinnati), garlic-infused extra virgin olive oil, August 29. Recalled because the garlic flavor came from a garlic essential oil not approved for culinary use; sold for a year at two Cincinnati locations and online, no illnesses (FDA announcement). Why it matters: an essential oil sold for aromatherapy or cosmetics and a food-grade flavoring can come from the same plant and the same distillery and still be different regulatory objects. Small-batch infused-oil, tea and cosmetics makers who buy essential oils from the same catalog: check which side of that line each one sits on.

📈 Watching for patterns

The recall you hear about from your supplier. Foods Alive this week, four repackers and a Whole Foods kitchen downstream of one jalapeño importer, the four unnamed consignees of Green Jeeva's bulk moringa in July, three seasoning makers downstream of one milk-powder lot in May, Walmart's berry blend downstream of one Chilean lot. In every case the brand on the recalled package had no failure in its own plant and no test of its own that would have caught it. FDA's enforcement records list the recalling firm; they do not list who else bought the same lot. That gap is where most of this summer's recalls lived.

✅ If you do one thing this week

Ask your bulk-powder or bulk-ingredient supplier one question in writing: "If any lot you sold me tests positive in anyone's hands, how and when will you tell me?" Keep the answer with the COA. If they cannot answer it, you already know how you will find out.

Question for you this week: has a supplier ever called you about a problem before FDA did? Hit reply, we read every answer.

And if you'd want alerts the moment one of YOUR suppliers, co-manufacturers, or competitors is cited, instead of checking FDA yourself, reply "watchlist" for early access.

Every action in this issue, and 220 more from this year, is on the register at enforcementweekly.com, with recall numbers and a plain-English read. Watch your own suppliers there, free: https://enforcementweekly.com/watch/.

FDA Enforcement Weekly is built from public FDA data by a small team that reads every enforcement action so you don't have to. Not affiliated with the FDA. Unsubscribe · Forward to a colleague who'd want this.